Cited by

• Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.

  Steele AD, Neuzil KM, Cunliffe NA, Madhi SA, Bos P, Ngwira B, Witte D, Todd S, Louw C, Kirsten M, Aspinall S, Van Doorn LJ, Bouckenooghe A, Suryakiran PV, Han HH. Steele AD, et al. BMC Infect Dis. 2012 Sep 13;12:213. doi: 10.1186/1471-2334-12-213. BMC Infect Dis. 2012. PMID: 22974466 Free PMC article. Clinical Trial.
• Rotavirus and Cryptosporidium pathogens as etiological proxies of gastroenteritis in some pastoral communities of the Amathole District Municipality, Eastern Cape, South Africa.

  Msolo L, Iweriebor BC, Okoh AI. Msolo L, et al. BMC Res Notes. 2020 Mar 30;13(1):187. doi: 10.1186/s13104-020-05024-2. BMC Res Notes. 2020. PMID: 32228662 Free PMC article.
• Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.

  Plosker GL. Plosker GL. Pharmacoeconomics. 2011 May;29(5):439-54. doi: 10.2165/11207130-000000000-00000. Pharmacoeconomics. 2011. PMID: 21504245 Review.
• CD4+ CD25- FoxP3+ regulatory cells are the predominant responding regulatory T cells after human rotavirus infection or vaccination in gnotobiotic pigs.

  Wen K, Li G, Yang X, Bui T, Bai M, Liu F, Kocher J, Yuan L. Wen K, et al. Immunology. 2012 Oct;137(2):160-71. doi: 10.1111/j.1365-2567.2012.03617.x. Immunology. 2012. PMID: 22716916 Free PMC article.
• Seasonal distribution of febrile seizure and the relationship with respiratory and enteric viruses in Korean children based on nationwide registry data.

  Han DH, Kim SY, Lee NM, Yi DY, Yun SW, Lim IS, Chae SA. Han DH, et al. Seizure. 2019 Dec;73:9-13. doi: 10.1016/j.seizure.2019.10.008. Epub 2019 Oct 18. Seizure. 2019. PMID: 31675516 Free PMC article.